(Q31886442)

4 July 2017

The effect of pharmacological doses of different antioxidants on oxidation parameters and atherogenesis in hyperlipidaemic rabbits (English)

1 reference

4 July 2017

1 reference

S Djahansouzi

1

1 reference

4 July 2017

J H Braesen

2

1 reference

4 July 2017

K Koenig

3

1 reference

4 July 2017

U Beisiegel

4

1 reference

4 July 2017

A Kontush

5

1 reference

4 July 2017

1 February 2001

1 reference

4 July 2017

1 reference

4 July 2017

154

1 reference

4 July 2017

2

1 reference

4 July 2017

387-398

1 reference

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Prevention of atherosclerotic progression in Watanabe rabbits by probucol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Antiatherosclerotic effect of probucol in WHHL rabbits: are there plasma parameters to evaluate this effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Vitamin E, antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

The antioxidant butylated hydroxytoluene protects against atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Antioxidants and atherosclerotic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand white rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Relation of vascular oxidative stress, alpha-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Coenzyme Q10 treatment may be protective during coronary artery bypass operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Anti-oxidants and pro-oxidants in coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

High-performance liquid chromatographic procedure for the determination of probucol in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Measurement of antioxidants in human blood plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Azodipyrroles of unconjugated and conjugated bilirubin using diazotized ethyl anthranilate in dimethyl sulfoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Measurement of oxidizability of blood plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Analysis of lipoprotein diene formation in human serum exposed to copper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits. An animal model for familial hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Evaluation of oxidative stress in patients with hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Alpha- and beta-carotenes in low density lipoprotein are the preferred target for nitric oxide-induced oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Inhibition of LDL oxidation by ubiquinol-10. A protective mechanism for coenzyme Q in atherogenesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Inhibition of IL-1 beta expression in THP-1 cells by probucol and tocopherol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

7 January 2021

Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

7 January 2021

Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

7 January 2021

Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900510-4

7 January 2021

10.1016/S0021-9150(00)00510-4

Identifiers

DOI

1 reference

4 July 2017

1 reference